Conversely, the prevalence of HαT-positive individuals is higher in patients with SM (12.2%–20%) and those with idiopathic anaphylaxis (17%) compared with controls (4%–7.5%).47,48,50,70 The same holds true for patients with nonclonal (secondary) MCAS. Here, TMPRSS11D is linked to systemic mastocytosis.